• C Andrejak, F-X Blanc, F Costes, B Crestani, D Debieuvre, T Perez, B Philippe, L Plantier, F Schlemmer, L Sesé, B Stach, Y Uzunhan, C Zanetti, M Zysman, C Raherison, and B Maitre.
• Service de pneumologie, UR 4294 AGIR, université Picardie Jules-Verne, CHU Amiens-Picardie, rond point Christian-Chabrol, 80054 Amiens, France. Electronic address: andrejak.claire@chu-amiens.fr.
• Rev Mal Respir. 2020 Jun 1; 37 (6): 505-510.

AbstractThe French-language Respiratory Medicine Society (SPLF) proposes a guide for the follow-up of patients who have presented with SARS-CoV-2 pneumonia. The proposals are based on known data from previous epidemics, on acute lesions observed in SARS-CoV-2 patients and on expert opinion. This guide proposes a follow-up based on three categories of patients: (1) patients managed outside hospital for possible or proven SARS-CoV-2 infection, referred by their physician for persistent dyspnoea; (2) patients hospitalized for SARS-CoV-2 pneumonia in a medical unit; (3) patients hospitalized for SARS-CoV-2 pneumonia in an intensive care unit. The subsequent follow-up will have to be adapted to the initial assessment. This guide emphasises the possibility of others causes of dyspnoea (cardiac, thromboembolic, hyperventilation syndrome…). These proposals may evolve over time as more knowledge becomes available.Copyright © 2020 SPLF. Published by Elsevier Masson SAS. All rights reserved.

53 keywords...

hide…